ImmuneWatch

ImmuneWatch

Foundation date

21/09/2021

Sector

#Biotechnology / R&D Services

Subsector

• #Therapeutics - Biosimilars
• #Therapeutics - Proteins
• #Therapeutics - Small molecules
• #R&D Services - Analytical services
• #R&D Services - Bioinformatics
• #R&D Services - CRO (Contract Research Organization)
• #R&D Services - Diagnostic services
• #R&D Services - Genomics
• #R&D Services - Screening
• #Pharma - Nucleic acid drugs

Therapeutic areas

• #Diseases of the blood and blood-forming organs - immune disorders
• #Infectious and parasitic diseases
• #Neoplasms / cancer / oncology
• #Symptoms - signs and abnormal clinical and laboratory findings - not elsewhere classified

At ImmuneWatch we want to accelerate the development of T-cell based diagnostic tools and therapies. Our mission is to make immune repertoire data interpretable and actionable by annotating T-cell receptors in a clinically meaningful way.